» Articles » PMID: 22234664

Arthroplasty in Veterans: Analysis of Cartilage, Bone, Serum, and Synovial Fluid Reveals Differences and Similarities in Osteoarthritis with and Without Comorbid Diabetes

Overview
Date 2012 Jan 12
PMID 22234664
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis patients with diabetes who receive total knee arthroplasty are more vulnerable to complications, including aseptic loosening and need for revision surgery. To elucidate mechanisms related to arthroplasty failure in diabetes, we examined serum and synovial fluid markers as well as collagen crosslinks in bone and cartilage of 20 patients (10 with diabetes, 10 controls without) undergoing this procedure. Hemoglobin A1c, body mass index, bone alkaline phosphatase, leptin, osteocalcin, and pyridinium were analyzed along with tissue content of the crosslinks hydroxylysylpyridinoline, lysylpyridinoline, and pentosidine. Pentosidine levels in tissue specimens from diabetic subjects were higher than in control subjects. Osteocalcin levels negatively correlated with hydroxylysylpyridinoline levels in cartilage. Osteocalcin levels also negatively correlated with pentosidine levels in cartilage, but only in subjects with diabetes. This study suggests potential metabolic mechanisms for arthroplasty failure in patients with diabetes.

Citing Articles

Causal link between metabolic related factors and osteoarthritis: a Mendelian randomization investigation.

Li K, Leng Y, Lei D, Zhang H, Ding M, Lo W Front Nutr. 2024; 11:1424286.

PMID: 39206315 PMC: 11349640. DOI: 10.3389/fnut.2024.1424286.


The metabolic characteristics and changes of chondrocytes and in osteoarthritis.

Adam M, Zhuang H, Ren X, Zhang Y, Zhou P Front Endocrinol (Lausanne). 2024; 15:1393550.

PMID: 38854686 PMC: 11162117. DOI: 10.3389/fendo.2024.1393550.


Impact of diabetes mellitus on osteoarthritis: a scoping review on biomarkers.

Seow S, Mat S, Ahmad Azam A, Rajab N, Safinar Ismail I, Singh D Expert Rev Mol Med. 2024; 26:e8.

PMID: 38606593 PMC: 11062141. DOI: 10.1017/erm.2024.7.


Advanced glycation and glycoxidation end products in bone.

Wang B, Vashishth D Bone. 2023; 176:116880.

PMID: 37579812 PMC: 10529863. DOI: 10.1016/j.bone.2023.116880.


Increased tissue modulus and hardness in the TallyHO mouse model of early onset type 2 diabetes mellitus.

Arora D, Taylor E, King K, Donnelly E PLoS One. 2023; 18(7):e0287825.

PMID: 37418415 PMC: 10328374. DOI: 10.1371/journal.pone.0287825.


References
1.
Achemlal L, Tellal S, Rkiouak F, Nouijai A, Bezza A, Derouiche E . Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol. 2005; 24(5):493-6. DOI: 10.1007/s10067-004-1070-9. View

2.
Pedersen A, Mehnert F, Johnsen S, Sorensen H . Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br. 2010; 92(7):929-34. DOI: 10.1302/0301-620X.92B7.24461. View

3.
Ducy P, Amling M, Takeda S, Priemel M, Schilling A, Beil F . Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000; 100(2):197-207. DOI: 10.1016/s0092-8674(00)81558-5. View

4.
Olsen A, Sarras Jr M, Intine R . Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus. Wound Repair Regen. 2010; 18(5):532-42. PMC: 2941236. DOI: 10.1111/j.1524-475X.2010.00613.x. View

5.
Eyre D, Paz M, Gallop P . Cross-linking in collagen and elastin. Annu Rev Biochem. 1984; 53:717-48. DOI: 10.1146/annurev.bi.53.070184.003441. View